Stock Analysts’ updated eps estimates for Wednesday, August 23rd:

Advanced Micro Devices (NASDAQ:AMD) had its outperform rating reaffirmed by analysts at Wells Fargo & Company.

Advanced Micro Devices (NASDAQ:AMD) had its buy rating reiterated by analysts at Rosenblatt Securities.

Atmos Energy Corporation (NYSE:ATO) had its price target raised by Argus from $92.00 to $97.00. Argus currently has a buy rating on the stock.

Broadcom Limited (NASDAQ:AVGO) had its buy rating reiterated by analysts at Rosenblatt Securities. Rosenblatt Securities currently has a $270.00 price target on the stock.

Alibaba Group Holding Limited (NYSE:BABA) had its target price increased by MKM Partners from $177.00 to $220.00. They currently have a buy rating on the stock.

Cheetah Mobile (NASDAQ:CMCM) had its target price raised by Nomura from $11.50 to $12.00. Nomura currently has a neutral rating on the stock.

Cheetah Mobile (NASDAQ:CMCM) had its neutral rating reiterated by analysts at Instinet. Instinet currently has a $12.00 price target on the stock, up from their previous price target of $11.50.

Coty (NYSE:COTY) had its price target trimmed by Morgan Stanley from $22.00 to $19.00. The firm currently has a weight rating on the stock.

Cree (NASDAQ:CREE) had its hold rating reaffirmed by analysts at Canaccord Genuity. The firm currently has a $23.00 price target on the stock.

Salesforce.com (NYSE:CRM) had its buy rating reiterated by analysts at Drexel Hamilton. They currently have a $111.00 target price on the stock.

Salesforce.com (NYSE:CRM) had its outperform rating reissued by analysts at BMO Capital Markets. BMO Capital Markets currently has a $100.00 price target on the stock.

Salesforce.com (NYSE:CRM) was given a $110.00 price target by analysts at Goldman Sachs Group, Inc. (The). The firm currently has a buy rating on the stock.

Salesforce.com (NYSE:CRM) was given a $120.00 target price by analysts at J P Morgan Chase & Co. The firm currently has a buy rating on the stock.

CenturyLink (NYSE:CTL) had its target price lowered by Morgan Stanley from $27.00 to $26.00. The firm currently has an overweight rating on the stock.

DSW (NYSE:DSW) had its buy rating reissued by analysts at Deutsche Bank AG. Deutsche Bank AG currently has a $22.00 target price on the stock, up from their previous target price of $21.00.

FireEye (NASDAQ:FEYE) had its buy rating reaffirmed by analysts at Goldman Sachs Group, Inc. (The). Goldman Sachs Group, Inc. (The) currently has a $19.00 price target on the stock.

Frontier Communications Corporation (NASDAQ:FTR) had its target price cut by Morgan Stanley to $16.00. Morgan Stanley currently has a weight rating on the stock.

Intel Corporation (NASDAQ:INTC) had its sell rating reiterated by analysts at Rosenblatt Securities.

Intuit (NASDAQ:INTU) had its buy rating reiterated by analysts at Bank of America Corporation. The firm currently has a $145.00 target price on the stock.

Lanxess AG (ETR:LXS) had its buy rating reiterated by analysts at DZ Bank AG.

Northrop Grumman (NYSE:NOC) had its conviction-buy rating reiterated by analysts at Goldman Sachs Group, Inc. (The). The firm currently has a $309.00 price target on the stock.

Pacira Pharmaceuticals (NASDAQ:PCRX) had its outperform rating reiterated by analysts at Wedbush. The firm currently has a $87.00 price target on the stock.

Dougherty & Co began coverage on shares of IMPINJ (NYSE:PI). They issued a buy rating on the stock.

Ultragenyx Pharmaceutical (NASDAQ:RARE) had its buy rating reiterated by analysts at Stifel Nicolaus. Stifel Nicolaus currently has a $85.00 target price on the stock, down from their previous target price of $95.00.

Ultragenyx Pharmaceutical (NASDAQ:RARE) had its outperform rating reiterated by analysts at Leerink Swann. Leerink Swann currently has a $83.00 target price on the stock, down from their previous target price of $89.00.

Ultragenyx Pharmaceutical (NASDAQ:RARE) had its outperform rating reissued by analysts at Cowen and Company.

Snap (NYSE:SNAP) had its price target lowered by Morgan Stanley from $16.00 to $14.00. The firm currently has a weight rating on the stock.

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) had its buy rating reissued by analysts at Dawson James. The firm currently has a $9.00 target price on the stock.

Dougherty & Co started coverage on shares of Transcat (NASDAQ:TRNS). The firm issued a buy rating on the stock.